Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study.

Hideyuki SoneSatoshi IgawaMasashi KasajimaMikiko IshiharaYasuhiro HiyoshiShinji HosotaniShuntaro OheHiroki ItoNobuki KaizukaHiroya ManakaTomoya FukuiHisashi MitsufujiMasaru KubotaMasato KatagiriJiichiro SasakiKatsuhiko Naoki

Published in: Thoracic cancer (2018)

AMR may be a feasible and effective regimen for elderly patients with relapsed SCLC.

Keyphrases

small cell lung cancer
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
hodgkin lymphoma
diffuse large b cell lymphoma
middle aged
community dwelling
open label
clinical trial
randomized controlled trial
antimicrobial resistance